Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-23

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
NeoPhore3 periods Neva First	Biotech	United Kingdom	Neva SGR	2021	5yr	Active	–	–
NeRRe Therapeutics2 periods Columbus Life Science Fund II	Biotech	United Kingdom	Columbus Venture Partners	2021	5yr	Active	–	–
ScienceMachine2 periods Vento Fund II	Biotech	United Kingdom	Vento	2025	1yr	Active	–	–
Tolemy Bio2 periods Big Sur Ventures Fund	Biotech	United Kingdom	Big Sur Ventures	2026	0yr	Active	–	–
Axiom Therapeutics Lunar Ventures Fund II	Biotech	United Kingdom	Lunar Ventures	–	–	Active	–	–
CamGene Therapeutics Parkwalk Opportunities EIS Fund	Biotech	United Kingdom	Parkwalk Advisors	2025	1yr	Active	–	–
Coherence Neuro Possible Ventures Fund III	Biotech	United Kingdom	Possible Ventures	2025	1yr	Active	–	–
CRANE BIOSCIENCES Norrsken Accelerator	Biotech	United Kingdom	Norrsken Accelerator	2024	2yr	Active	–	–
CraneBio Vento Fund I	Biotech	United Kingdom	Vento	2023	3yr	Active	–	–
Cytospire Criteria Bio Ventures	Biotech	United Kingdom	Caixa Capital Risc	2026	0yr	Active	–	–
EpilepsyGTx XGEN Venture Life Sciences Fund	Biotech	United Kingdom	XGen Venture SGR	2025	1yr	Active	–	–
F2G Limited Novo Holdings Growth Investments	Biotech	United Kingdom	Novo Holdings	2016	10yr	Active	–	–
General Biotechnologies Kompas Fund II	Biotech	United Kingdom	Kompas Vc	2026	0yr	Active	–	–
Kiin Bio Heartfelt Fund I	Biotech	United Kingdom	Heartfelt	2025	1yr	Active	–	–
NetZeroNitrogen Revent Fund I	Biotech	United Kingdom	Revent	2023	3yr	Active	–	–
Ochre Bio Apollo Health Ventures Fund II	Biotech	United Kingdom	Apollo Health Ventures	2021	5yr	Active	–	–
Portal Biotech Earlybird Health	Biotech	United Kingdom	Earlybird Venture Capital	2025	1yr	Active	–	–
Prokarium Flerie Invest	Biotech	United Kingdom	Flerie	2014	12yr	Active	–	–
Rathlin Therapeutics Columbus Life Sciences Fund IV	Biotech	United Kingdom	Columbus Venture Partners	2023	3yr	Active	–	–
Redx Pharma Sofinnova Crossover Fund I	Biotech	United Kingdom	Sofinnova Partners	2019	7yr	Active	–	–
RoukenBio NorthEdge Fund III	Biotech	United Kingdom	NorthEdge Capital	2023	3yr	Active	–	–
Sidera Bio Novo Holdings Venture Investments	Biotech	United Kingdom	Novo Holdings	2024	2yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.